semaglutide phase 2 Approved for Type Diabetes Efficacy and safety of once-weekly

Our products are crafted for research and/or investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use

The anti-inflammatory properties of GLP-1 agonists are very potent in their therapeutic application

At-Home Administration A registered nurse administers your Semaglutide/Tirzepatide injections at your home, ensuring your comfort and convenience

Both the subcutaneous and oral formulations of semaglutide have undergone extensive phase 3 clinical testing ( Table 1 )

Theyve also been used to help treat loss of smell (called anosmia) in patients with Parkinson's, Alzheimer's, and dementia

Step 1: Store Your GLP-1 Medication Correctly All GLP-1 receptor agonists are temperature-sensitive biologics